people with IPF are in greater danger if they are infected with Covid-19
medical studies and anecdotal evidence suggests that Covid-19 is complicit in the onset of IPF
The big question is;
can the progression of pulmonary fibrosis be stopped if detected in time?
The medical studies understandably refer to SARS and MERS which are historical examples of an outbreak of coronavirus. Nonetheless, there are preliminary studies and observations being made in relation to Covid-19. It appears that patients are developing lung scarring following infection with Covid-19. In future, there will be an avalanche of research into the topic because as stated in my previous post, the potential for an increased incidence of lung scarring is an ugly spectre to be hanging over the population.
So its early days but critical days in formulating a response. The announcement by AdAlta this morning is an initial public response which may herald other developments. Beyond a vaccine for Covid-19 there will be a push into treatments for IPF as well as preventative treatments in relation to stopping the progression of the onset of pulmonary fibrosis.
1AD Price at posting:
5.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)